Key Takeaways
- Arm surpassed Q4 projections with earnings per share of $0.60 versus consensus of $0.58, and revenue of $1.49B against $1.47B expected
- Shares initially surged 12-13% in extended trading before reversing course to drop 5%
- AGI CPU orders topped $2 billion in value, though manufacturing capacity secured for only half that amount
- Production bottlenecks led executives to maintain conservative revenue outlook
- The company is transitioning from design licensing to chip manufacturing, increasing operational expenses
Arm Holdings delivered fourth-quarter fiscal 2026 results that topped analyst projections, yet shares couldn’t sustain their momentum. Following an initial surge of up to 13% during after-hours activity, ARM reversed sharply to close down more than 5% as market participants focused on production capacity challenges.
Arm Holdings plc American Depositary Shares, ARM
The semiconductor designer posted adjusted profit of $0.60 per share against sales of $1.49 billion. Wall Street consensus had called for $0.58 per share with revenue of $1.47 billion.
Licensing income increased 29% from the prior year to $819 million. Royalty income advanced 11% year-over-year to $671 million.
The initial share price jump reflected the solid financial performance. The subsequent decline reflected investor concerns raised during the earnings call.
Chief Executive Rene Haas disclosed that orders for Arm’s recently introduced AGI CPU — unveiled in March — have already exceeded $2 billion merely six weeks following its debut, representing more than twice the initial launch announcement. This represented the positive development.
The challenge involves manufacturing capacity. Leadership acknowledged securing sufficient wafers, memory components, and packaging materials to satisfy only the initial $1 billion of accumulated orders. The additional $1 billion in demand remains under negotiation.
Raymond James analyst Simon Leopold observed that manufacturing limitations prompted management to maintain its existing revenue projections.
Production Constraints Trigger Selloff
The disparity between $2 billion in customer orders and $1 billion in confirmed manufacturing capability appeared to represent the catalyst for the overnight stock decline.
Arm’s first-quarter fiscal 2027 outlook projected adjusted earnings per share of $0.40, with a variance of $0.04, alongside revenue of $1.26 billion, with a $50 million range. Wall Street had anticipated $1.25 billion in sales, placing guidance essentially in line with expectations.
Notwithstanding the earnings beat and robust AGI CPU order activity, market participants seemed reluctant to overlook the execution challenges surrounding supply chain management.
Transition to Capital-Intensive Operations
For many years, Arm operated with a relatively asset-light structure — providing chip architecture designs to companies like Apple, Qualcomm, Nvidia, and Samsung, subsequently earning royalty payments based on unit shipments.
The company is now entering direct chip production. The AGI CPU represents Arm’s initial internally developed processor targeting AI infrastructure applications, necessitating procurement of cutting-edge 3nm wafers from TSMC alongside oversight of its production operations.
This represents a significantly more capital-demanding approach. Industry analysts have highlighted that elevated operating costs could compress profit margins if revenue expansion fails to accelerate proportionally.
Arm leadership conveyed optimism in their communication to shareholders. “The trajectory is unmistakable: clients are positioning Arm at the core of AI data center infrastructure,” Haas and CFO Jason Child stated.
They further indicated the data center division is progressing toward a $15 billion revenue milestone, with expectations it will emerge as Arm’s dominant business segment.
ARM shares have climbed more than 115% throughout 2026, establishing elevated expectations heading into the quarterly report. Analyst consensus currently reflects a Strong Buy rating, comprising 18 Buy recommendations, 3 Hold ratings, and 1 Sell rating across the most recent three-month period.
The consensus price target among analysts stands at $188.52 per share.


